Medical Advocates
 

Kaletra Library Service 
Conference Abstracts and Posters

Last Update:  December 08, 2014    Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader   A WEEK IN REVIEW FEATURED REPORT POSTER Week-96 end of trial analysis of antiretroviral-naïve patients randomized to the lopinavir/ritonavir single drug arm in the MONARK trial J. Ghosn, P. Flandre, C. Delaugerre, et al PDF Poster     Abstract POSTER Predictors of Persistence with Lopinavir/ritonavir (LPV/r) Soft-Gelatin Capsule-Based Antiretroviral Regimens R Rode, Q Feng, T Podsadecki, et al PDF Poster     Abstract POSTER Trough Lopinavir Concentrations <1 μg/mL Are Not Associated with Virologic Failure in Antiretroviral-Naïve Patients Receiving a Lopinavir/ritonavir-Based 3-Drug Regimen Y-L Chiu, C Enders Klein, J Li, et al PDF Poster    Abstract POSTER Impact of Gender on Response to Lopinavir/ritonavir (LPV/r) Tablets Dosed QD or BID Administered with Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine (FTC) in Antiretroviral-naïve (ARV) Subjects: Results from Study M05-730 B da Silva, D Cohen, S Gibbs, et al PDF Poster   Abstract POSTER Comparable HIV-1 Viral Suppression and Immunologic Recovery of White and Non-White Antiretroviral-Naïve Subjects Taking Lopinavir/ritonavir (LPV/r) Tablets + Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine (FTC) through 48 Weeks B da Silva, D Cohen, S Gibbs, et al PDF Poster   POSTER Lopinavir/ritonavir (LPV/r) in Pregnancy SS Roberts, M Martinez, DL.Covington, et al PDF Poster Effects of lopinavir/ritonavir-based therapy on the lipograms of young children R. Strehlau , A. Coovadia , T. Meyers Resistance to LPV, TPV and DRV according to three different algorithms in samples from highly antiretroviral-therapy experienced-patients in Mexico City A. Campos, R.A. Rodríguez-Díaz, L.L. Fuentes-Romero, L.E. Soto-Ramírez Pharmacokinetics of lopinavir in the LPV/r-Meltrex formulation compared to the LPV/r-soft gelatine capsule in HIV-infected patients P. Langmann, M. Leyh, H. Klinker, et al Response to treatment with lopinavir/ritonavir among mexican HIV-infected children and adolescents R. Muñoz-Hernandez, D. Jarillo-Quijada, N. Pavia-Ruz, et al Evaluation of adherence to antiretroviral regimen- containing Kaletra in a group of adolescents with chronic HIV-1 infection from Romania t D. Duiculescu A. Blaglosov, A. Luca, et al A new simple and useful immunoenzymatic test to monitoring adherence and through levels of lopinavir in HIV-infected children R. Rosso, F. Miletich, L. Nulvesu, et al Unexpected high failure rate of lopinavir (LPV/r) monotherapy F. Zenger , A. Cusini  , C. Fux,  et al Switching from lopinavir/r capsules to lopinavir/r tablets. Is there an improvement of gastrointestinal complaints? C. Koegl, E. Wolf, A. Eberhard, et al A randomised trial of lopinavir/ritonavir (LPV/r) monotherapy vs continued HAART in patients on suppressive therapy L. Waters, A. Jackson, K. Singh, et al Safety and tolerability of the lopinavir/ritonavir (LPV/r) tablet in comparison to other protease inhibitors (PIs): the SAPIKAT trial U.F. Bredeek, B. Williams, R. Rhode, et al Impact of a lopinavir/ritonavir (Kaletra) based second-line antiretroviral therapy regimen on lipid and lipoprotein profiles in an African setting Z. Gomo, S. Walker, J. Hakim, et al A pilot study assessing once-daily lopinavir/ritonavir (LPV/r) oral solution (OS) with fixed dose emtricitibine/tenofivir (FTC/TDF) as the initial HAART in antiretroviral naïve HIV-infected subjects S. Schrader, R. Andrade, E. Villarreal-Williams, et al Lopinavir-ritonavir plus nevirapine as a strategy to improve nucleoside-related mitochondrial toxicity in chronically treated HIV-infected patients: 48 week follow-up of MULTINEKA study E. Negredo, O. Miró, G. Garrabou, et al Different effects on body composition between men and women switching triple therapy with lopinavir-ritonavir (LPV/rtv) and two nucleoside analogs (NRTIs) to lopinavir-ritonavir plus nevirapine (NVP) for maintenance therapy of HIV infection: MULTINEKA substudy C. Estany, E. Negredo, E. Martinez-Lope, et al

KLS Main Page

KLS Conference Index

Home

XVII International AIDS Conference